Twin Tree Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,000
Closed -$241K 1650
2025
Q4
$241K Sell
1,000
-37,500
-97% -$9.59M ﹤0.01% 1230
2025
Q3
$10.5M Sell
38,500
-52,000
-57% -$14.2M 0.04% 482
2025
Q2
$23.3M Buy
90,500
+62,200
+220% +$14.8M 0.04% 427
2025
Q1
$6.33M Sell
28,300
-35,700
-56% -$8.33M 0.01% 827
2024
Q4
$14.6M Sell
64,000
-116,200
-64% -$28M 0.03% 564
2024
Q3
$44M Sell
180,200
-72,500
-29% -$16.2M 0.09% 192
2024
Q2
$48.4M Buy
+252,700
New +$51.3M 0.11% 170
2020
Q4
Sell
-22,300
Closed -$3.82M 1461
2020
Q3
$3.82M Sell
22,300
-30,600
-58% -$5.65M 0.02% 639
2020
Q2
$10.2M Buy
52,900
+37,100
+235% +$6.07M 0.04% 458
2020
Q1
$2.33M Sell
15,800
-2,200
-12% -$350K 0.01% 677
2019
Q4
$2.79M Buy
18,000
+2,700
+18% +$389K 0.01% 643
2019
Q3
$2.07M Buy
+15,300
New +$2M 0.01% 678
2015
Q3
Sell
-7,900
Closed -$445K 1486
2015
Q2
$445K Buy
+7,900
New +$499K 0.01% 906

Other funds holding RMD

Twin Tree Management's RMD Position: Q2 2025 in Review

Twin Tree Management sold out of ResMed (RMD) in Q2 2025, closing a stake of 1,465 shares — an estimated $349K sold.

Twin Tree Management first reported a position in RMD in Q4 2015 and held it in 21 quarters. The position peaked at $22.6M in Q4 2023. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

  • Twin Tree Management reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
  • Twin Tree Management sold 1,465 ResMed shares in Q2 2025, an estimated $349K.
  • Twin Tree Management first reported a position in ResMed in Q4 2015 and held it in 21 quarters.
  • Twin Tree Management's ResMed position peaked at $22.6M in Q4 2023.
  • 919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Twin Tree Management's 13F filing for Q2 2025, filed 28 Jul 2025.